» Articles » PMID: 26472336

Pathogenesis and Treatment of Psoriasis: Exploiting Pathophysiological Pathways for Precision Medicine

Overview
Specialty Rheumatology
Date 2015 Oct 17
PMID 26472336
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a common, chronic inflammatory skin disease associated with multi-system manifestations including arthritis and obesity. Our knowledge of the aetiology of the condition, including the key genomic, immune and environmental factors, has led to the development of targeted, precision therapies that alleviate patient morbidity. This article reviews the key pathophysiological pathways and therapeutic targets and highlights future areas of interest in psoriasis research.

Citing Articles

Exploring the Relationship Between Psychiatric Illness and Dermatological Disorders: A Narrative Review.

Kaye A, Islam R, Castine A, Wester G, Barham W, Nguyen C Cureus. 2025; 17(2):e78731.

PMID: 40065888 PMC: 11892542. DOI: 10.7759/cureus.78731.


Green Nail in a Patient With Psoriasis Receiving Deucravacitinib.

Mima Y, Ohtsuka T, Norimatsu Y Cureus. 2025; 16(12):e75906.

PMID: 39830543 PMC: 11739536. DOI: 10.7759/cureus.75906.


IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?.

Cui X, Liu W, Jiang H, Zhao Q, Hu Y, Tang X J Transl Autoimmun. 2025; 10:100263.

PMID: 39759268 PMC: 11697604. DOI: 10.1016/j.jtauto.2024.100263.


The prognostic impact of stress hyperglycemia ratio for all-cause mortality in patients with Psoriasis.

Tuersun G, Alifu J, Qu Y, Kang X Sci Rep. 2024; 14(1):26113.

PMID: 39478002 PMC: 11525686. DOI: 10.1038/s41598-024-77019-z.


The Impact of Statins on Disease Severity and Quality of Life in Patients with Psoriasis: A Systematic Review and Meta-Analysis.

Aleid A, Almutairi G, Alrizqi R, Nukaly H, Alkhanani J, AlHuraish D Healthcare (Basel). 2024; 12(15).

PMID: 39120229 PMC: 11311713. DOI: 10.3390/healthcare12151526.